DIAGNOS célèbre le lancement du nouveau service de dépistage de la rétinopathie diabétique de Labtician en Ontario et renouvelle son entente de distribution
May 21, 2024 09:00 ET
|
DIAGNOS inc.
BROSSARD, Québec, 21 mai 2024 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un pionnier dans la détection précoce de...
DIAGNOS celebrates the launch of Labtician’s new screening service for diabetic retinopathy in Ontario and renews its distribution agreement
May 21, 2024 09:00 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, May 21, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through its...
DIAGNOS Announces Closing of First Tranche of Private Placement
May 09, 2024 16:15 ET
|
DIAGNOS Inc.
DIAGNOS Announces Closing of First Tranche of Private Placement
SchooLinks Recognized Among America's Best Startup Employers by Forbes and Inc.
May 08, 2024 07:15 ET
|
SchooLinks
Austin, TX, May 08, 2024 (GLOBE NEWSWIRE) -- SchooLinks, the most innovative platform for college and career readiness, is proud to announce its recent achievements in both business growth and...
DIAGNOS présentera des solutions d'IA de pointe pour la santé rétinienne à ARVO 2024
May 06, 2024 09:00 ET
|
DIAGNOS inc.
BROSSARD, Québec, 06 mai 2024 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un pionnier dans le dépistage précoce de...
DIAGNOS to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024
May 06, 2024 09:00 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, May 06, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain...
DIAGNOS accélérera la demande de licence d'instrument médical à Santé Canada et à la FDA des États-Unis concernant ses 4 nouveaux modules d'analyse, et prévoit la certification ISO 27001
April 16, 2024 11:08 ET
|
DIAGNOS inc.
BROSSARD, Québec, 16 avr. 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (« DIAGNOS » ou « la Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un fournisseur de services de soins de santé en...
DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification
April 16, 2024 11:08 ET
|
DIAGNOS Inc.
BROSSARD, Quebec, April 16, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain...
Inc.’s 2024 Female Founders list highlights why female founders are always a good bet
April 09, 2024 12:19 ET
|
Adyn, Inc.
Inc’s 2024 Female Founders list highlights why female founders are always a good bet. adyn founder, Elizabeth Ruzzo, is named to the list.
DIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11th
April 09, 2024 10:10 ET
|
DIAGNOS Inc.
MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (ADK TSX: OTCQB: DGNOF), based in Montreal, Canada, focused on Artificial Intelligence for the medical market, today announced that André...